Jennison Associates LLC Argenx Se Transaction History

Jennison Associates LLC

  • $155 Billion
  • Q2 2024

A detailed history of Jennison Associates LLC transactions in Argenx Se stock. As of the latest transaction made, Jennison Associates LLC holds 236,438 shares of ARGX stock, worth $134 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
236,438
Previous 233,417 1.29%
Holding current value
$134 Million
Previous $91.9 Million 10.64%
% of portfolio
0.07%
Previous 0.06%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024
BUY
$356.01 - $451.55 $1.08 Million - $1.36 Million
3,021 Added 1.29%
236,438 $102 Million
Q1 2024

May 02, 2024
SELL
$356.95 - $413.29 $12.4 Million - $14.4 Million
-34,791 Reduced 12.97%
233,417 $91.9 Million
Q4 2023

Feb 01, 2024
SELL
$338.91 - $506.01 $421 Million - $629 Million
-1,243,537 Reduced 82.26%
268,208 $102 Million
Q3 2023

Oct 31, 2023
BUY
$369.35 - $548.43 $136 Million - $202 Million
368,367 Added 32.22%
1,511,745 $743 Million
Q2 2023

Aug 03, 2023
BUY
$360.14 - $422.58 $1.95 Million - $2.29 Million
5,412 Added 0.48%
1,143,378 $446 Million
Q1 2023

Apr 26, 2023
SELL
$334.23 - $403.65 $115 Million - $139 Million
-344,926 Reduced 23.26%
1,137,966 $424 Million
Q4 2022

Feb 09, 2023
SELL
$342.17 - $402.31 $22.6 Million - $26.6 Million
-66,173 Reduced 4.27%
1,482,892 $562 Million
Q3 2022

Nov 01, 2022
BUY
$343.2 - $395.75 $1.32 Million - $1.52 Million
3,838 Added 0.25%
1,549,065 $547 Million
Q2 2022

Aug 02, 2022
BUY
$269.58 - $378.88 $142 Million - $200 Million
527,812 Added 51.88%
1,545,227 $585 Million
Q1 2022

May 11, 2022
BUY
$254.45 - $351.06 $49.1 Million - $67.7 Million
192,844 Added 23.39%
1,017,415 $321 Million
Q4 2021

Feb 08, 2022
SELL
$272.01 - $353.03 $2.06 Million - $2.67 Million
-7,574 Reduced 0.91%
824,571 $289 Million
Q3 2021

Nov 09, 2021
BUY
$295.0 - $350.58 $23.8 Million - $28.3 Million
80,790 Added 10.75%
832,145 $251 Million
Q2 2021

Aug 12, 2021
BUY
$257.11 - $319.92 $8.11 Million - $10.1 Million
31,540 Added 4.38%
751,355 $226 Million
Q1 2021

May 11, 2021
BUY
$268.3 - $380.31 $81.1 Million - $115 Million
302,188 Added 72.36%
719,815 $198 Million
Q4 2020

Feb 05, 2021
SELL
$248.13 - $308.36 $2.42 Million - $3 Million
-9,738 Reduced 2.28%
417,627 $123 Million
Q3 2020

Nov 04, 2020
SELL
$215.51 - $272.51 $5.62 Million - $7.11 Million
-26,085 Reduced 5.75%
427,365 $112 Million
Q2 2020

Aug 06, 2020
BUY
$127.44 - $232.72 $5.96 Million - $10.9 Million
46,732 Added 11.49%
453,450 $102 Million
Q1 2020

May 06, 2020
BUY
$108.83 - $165.23 $14.3 Million - $21.8 Million
131,737 Added 47.91%
406,718 $53.6 Million
Q4 2019

Feb 07, 2020
BUY
$106.59 - $164.21 $6.03 Million - $9.29 Million
56,547 Added 25.89%
274,981 $44.1 Million
Q3 2019

Nov 08, 2019
SELL
$113.31 - $150.51 $18 Million - $23.9 Million
-158,674 Reduced 42.08%
218,434 $24.9 Million
Q2 2019

Aug 06, 2019
SELL
$115.0 - $141.58 $15.3 Million - $18.8 Million
-132,760 Reduced 26.04%
377,108 $0
Q1 2019

May 10, 2019
BUY
$98.85 - $134.59 $286,368 - $389,907
2,897 Added 0.57%
509,868 $63.7 Million
Q4 2018

Feb 06, 2019
SELL
$63.81 - $109.82 $271,192 - $466,735
-4,250 Reduced 0.83%
506,971 $48.7 Million
Q3 2018

Nov 08, 2018
BUY
$75.5 - $96.63 $13.5 Million - $17.3 Million
179,208 Added 53.98%
511,221 $38.8 Million
Q2 2018

Aug 02, 2018
BUY
$74.84 - $100.16 $394,855 - $528,444
5,276 Added 1.61%
332,013 $27.5 Million
Q1 2018

Apr 20, 2018
BUY
$56.95 - $85.19 $2.27 Million - $3.4 Million
39,925 Added 13.92%
326,737 $26.3 Million
Q4 2017

Jan 25, 2018
BUY
$22.57 - $63.56 $3.65 Million - $10.3 Million
161,846 Added 129.51%
286,812 $18.1 Million
Q3 2017

Nov 03, 2017
BUY
$19.81 - $22.61 $2.48 Million - $2.83 Million
124,966
124,966 $2.8 Million

Others Institutions Holding ARGX

# of Institutions
376
Shares Held
31.6M
Call Options Held
303K
Put Options Held
429K
View Full List

About ARGENX SE

ARGX Quotes by TradingView
  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $31.3B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Jennison Associates LLC Portfolio

Follow Jennison Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jennison Associates LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email